Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Mr. David G. ElsleyPresident, CEO & Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 675,00k | 107,69% |
| 2025-12-03 | Mr. Christopher J. WaddickCFO, Corporate Secretary & Director | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 250,00k | - |
| 2025-12-03 | Mr. Colin G. StottIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Ms. Jennifer M. ChaoIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Mr. Peter PekosIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 250,00k | - |
| 2025-12-03 | Ms. Teri LoxamIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 120,00k | 100,00% |
| 2025-12-03 | Dr. Guillermo Torre-AmioneIndependent Chairman | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 60,00k | - |
| 2025-12-03 | Mr. Bernard LimCOO | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 250,00k | - |
| 2025-12-03 | Dr. Timothy J. GarnettIndependent Director | 60,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,00 | 120,00k | 100,00% |
| 2025-10-01 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 133,33k | 0,00 | Derivative Exercise and Retained Stock | - | 669,95k | 24,85% |
| 2025-10-17 | Mr. David G. ElsleyPresident, CEO & Director | 100,00k | 100,00k | Kauf | 1,00 | 1,34M | 8,04% |
| 2025-10-17 | Dr. Guillermo Torre-AmioneIndependent Chairman | 50,00k | 50,00k | Kauf | 1,00 | 309,31k | 19,28% |
| 2025-09-08 | Ms. Teri LoxamIndependent Director | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 133,33k | 11,11% |
| 2025-09-08 | Ms. Jennifer M. ChaoIndependent Director | 13,33k | 0,00 | Derivative Exercise and Retained Stock | - | 133,33k | 11,11% |
| 2025-09-08 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 70,00k | 0,00 | Derivative Exercise and Retained Stock | - | 536,61k | 15,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
